NIDEK introduces AngioScan OCT Angiography for use with RS-3000 Advance OCT

NewsGuard 100/100 Score

NIDEK CO., LTD., a global leader in the design, manufacture, and distribution of ophthalmic, optometric, and lens edging equipment, is pleased to announce the launch of AngioScan OCT Angiography that enables visualization of retinal and choroidal microvasculature and blood flow with the RS-3000 Advance OCT.

OCT Angiography is a non-invasive technique that does not require injection of contrast dye for layer-by-layer examination of the retinochoroidal vasculature. OCT Angiography allows greater visualization of deep and small capillary plexus which is a significant advancement for clinical evaluation of retinal disease compared to conventional OCT or fluorescein angiography.

AngioScan features the tracing HD function which tracks eye movements to maintain the same scan location for accurate image acquisition. Tracing HD function can be enabled for exquisite high resolution image capture, or it can be turned off for faster image acquisition based on the clinical case. The scan size ranges from 3 mm to maximum of 9 mm and users can compose panorama images up to 12 mm x 9 mm.

The RS-3000 Advance models can be upgraded to AngioScan OCT by a simple software upgrade. The functionality of RS-3000 Advance combined with this software allows evaluation of retina in greater detail helping with the diagnosis and enhancing patient care.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Non-invasive imaging test identifies patients needing heart procedures